Predictive Oncology Declares 1-for-15 Reverse Stock Split of Common Shares
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Reverse Stock Split Announcement: Predictive Oncology Inc. (POAI) has announced a 1-for-15 reverse stock split of its common stock, effective September 30, 2025, where every 15 shares will be combined into one share.
Compliance with Nasdaq Requirements: The reverse stock split aims to help the company meet the minimum bid price requirement for maintaining its listing on the Nasdaq Capital Market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
